bioAffinity Technologies receives Japanese patent for CyPath Lung test to detect lung cancer early
bioAffinity Technologies Inc, a biotechnology company focused on the need for noninvasive tests for the detection of early─stage lung cancer and other lung diseases, announced that the Japan Patent Office has issued a
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →